A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
NCT ID: NCT00134147
Last Updated: 2008-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1100 participants
INTERVENTIONAL
2005-04-30
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inhaled Insulin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Failing two or more oral anti-diabetic agents
Exclusion Criteria
* Smoking
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
La Jolla, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
Washington D.C., District of Columbia, United States
Pfizer Investigational Site
Jacksonville, Florida, United States
Pfizer Investigational Site
Jacksonville, Florida, United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
Columbus, Georgia, United States
Pfizer Investigational Site
Overland Park, Kansas, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
Pfizer Investigational Site
Baltimore, Maryland, United States
Pfizer Investigational Site
Charlotte, North Carolina, United States
Pfizer Investigational Site
Charlotte, North Carolina, United States
Pfizer Investigational Site
Raleigh, North Carolina, United States
Pfizer Investigational Site
Medford, Oregon, United States
Pfizer Investigational Site
Hershey, Pennsylvania, United States
Pfizer Investigational Site
Spartanburg, South Carolina, United States
Pfizer Investigational Site
San Antonio, Texas, United States
Pfizer Investigational Site
San Antonio, Texas, United States
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Red Deer, Alberta, Canada
Pfizer Investigational Site
Winnipeg, Manitoba, Canada
Pfizer Investigational Site
Corunna, Ontario, Canada
Pfizer Investigational Site
Oakville, Ontario, Canada
Pfizer Investigational Site
Smith Falls, Ontario, Canada
Pfizer Investigational Site
Charlottetown, Prince Edward Island, Canada
Pfizer Investigational Site
Laval, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Béthune, , France
Pfizer Investigational Site
Bourg-en-Bresse, , France
Pfizer Investigational Site
Bron, , France
Pfizer Investigational Site
Corbeil-Essonnes, , France
Pfizer Investigational Site
La Rochelle, , France
Pfizer Investigational Site
Montpellier, , France
Pfizer Investigational Site
Nantes, , France
Pfizer Investigational Site
Roubaix, , France
Pfizer Investigational Site
Tours, , France
Pfizer Investigational Site
Altenburg, , Germany
Pfizer Investigational Site
Aschaffenburg, , Germany
Pfizer Investigational Site
Bad Mergentheim, , Germany
Pfizer Investigational Site
Bad Oeynhausen/ Volmerdingen, , Germany
Pfizer Investigational Site
Berlin, , Germany
Pfizer Investigational Site
Berlin, , Germany
Pfizer Investigational Site
Berlin, , Germany
Pfizer Investigational Site
Delmenhorst, , Germany
Pfizer Investigational Site
Dresden, , Germany
Pfizer Investigational Site
Ebersdorf, , Germany
Pfizer Investigational Site
Eisenach, , Germany
Pfizer Investigational Site
Falkensee, , Germany
Pfizer Investigational Site
Furth im Wald, , Germany
Pfizer Investigational Site
Hamburg, , Germany
Pfizer Investigational Site
Hamburg, , Germany
Pfizer Investigational Site
Haßloch, , Germany
Pfizer Investigational Site
Künzing, , Germany
Pfizer Investigational Site
Leipzig, , Germany
Pfizer Investigational Site
Meissen, , Germany
Pfizer Investigational Site
Mittweida, , Germany
Pfizer Investigational Site
Münster, , Germany
Pfizer Investigational Site
Münster, , Germany
Pfizer Investigational Site
Offenbach, , Germany
Pfizer Investigational Site
Offenburg, , Germany
Pfizer Investigational Site
Oschatz, , Germany
Pfizer Investigational Site
Pirna, , Germany
Pfizer Investigational Site
Riedlhuette, , Germany
Pfizer Investigational Site
Riesa, , Germany
Pfizer Investigational Site
Rossach, , Germany
Pfizer Investigational Site
Schwabenheim, , Germany
Pfizer Investigational Site
St.Ingbert, , Germany
Pfizer Investigational Site
Surwold, , Germany
Pfizer Investigational Site
Wangen, , Germany
Pfizer Investigational Site
Wangen / Allgaeu, , Germany
Pfizer Investigational Site
Witten, , Germany
Pfizer Investigational Site
Bari, , Italy
Pfizer Investigational Site
Catania, , Italy
Pfizer Investigational Site
Florence, , Italy
Pfizer Investigational Site
Genova, , Italy
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Napoli, , Italy
Pfizer Investigational Site
Padua, , Italy
Pfizer Investigational Site
Palermo, , Italy
Pfizer Investigational Site
Pescara, , Italy
Pfizer Investigational Site
Pisa, , Italy
Pfizer Investigational Site
Roma, , Italy
Pfizer Investigational Site
Torino, , Italy
Pfizer Investigational Site
Udine, , Italy
Pfizer Investigational Site
Verona, , Italy
Pfizer Investigational Site
Badalona, Barcelona, Spain
Pfizer Investigational Site
Barcelona, BARCELONA, Spain
Pfizer Investigational Site
Barcelona, BARCELONA, Spain
Pfizer Investigational Site
Barcelona, BARCELONA, Spain
Pfizer Investigational Site
Cadiz, CADIZ, Spain
Pfizer Investigational Site
Girona, GERONA, Spain
Pfizer Investigational Site
Granada, GRANADA, Spain
Pfizer Investigational Site
Las Palmas, LAS Palmas de GRAN Canaria, Spain
Pfizer Investigational Site
Madrid, Madrid, Spain
Pfizer Investigational Site
Madrid, Madrid, Spain
Pfizer Investigational Site
Seville, SEVILLA, Spain
Pfizer Investigational Site
Valencia, Valencia, Spain
Pfizer Investigational Site
Barakaldo, VIZCAYA, Spain
Pfizer Investigational Site
Bilbao, VIZCAYA, Spain
Pfizer Investigational Site
Ayr, Ayrshire, United Kingdom
Pfizer Investigational Site
Thornhill, Cardiff, United Kingdom
Pfizer Investigational Site
Penzance, CORNWALL, United Kingdom
Pfizer Investigational Site
St Austell, Cornwall, United Kingdom
Pfizer Investigational Site
Truro, Cornwall, United Kingdom
Pfizer Investigational Site
Plymouth, DEVON, United Kingdom
Pfizer Investigational Site
Letchworth Garden City, Hertfordshire, United Kingdom
Pfizer Investigational Site
Sidcup, Kent, United Kingdom
Pfizer Investigational Site
Whitstable, Kent, United Kingdom
Pfizer Investigational Site
Blackpool, Lancashire, United Kingdom
Pfizer Investigational Site
Colney, Norwich, United Kingdom
Pfizer Investigational Site
Headington, Oxford, United Kingdom
Pfizer Investigational Site
Penarth, South Glamorgan, United Kingdom
Pfizer Investigational Site
Dundee, Tayside, United Kingdom
Pfizer Investigational Site
Haywards Heath, West Sussex, United Kingdom
Pfizer Investigational Site
Birmingham, , United Kingdom
Pfizer Investigational Site
Bolton, , United Kingdom
Pfizer Investigational Site
Canterbury, , United Kingdom
Pfizer Investigational Site
Liverpool, , United Kingdom
Pfizer Investigational Site
Salford, , United Kingdom
Pfizer Investigational Site
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Freemantle N, Strack TR; Real World Trialists. Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial. Trials. 2006 Aug 10;7:25. doi: 10.1186/1745-6215-7-25.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A2171018
Identifier Type: -
Identifier Source: org_study_id